Status:
UNKNOWN
Diazoxide In the Management Of Hypoglycemic Neonates
Lead Sponsor:
University of Saskatchewan
Conditions:
Infant, Newborn, Diseases
Pregnancy in Diabetics
Eligibility:
All Genders
Up to 12 years
Phase:
PHASE2
PHASE3
Brief Summary
Diazoxide is an oral hyperglycemic medication. Diazoxide has been proven effective for treating hypoglycemia in infants and children with some types of persistent hyperinsulinemic hypoglycemia. The me...
Eligibility Criteria
Inclusion
- Infants of diabetic mothers (IDMs) or infants weighing \>90%
- Hypoglycemia: two consecutive blood glucose measurements \<2.6mol/L and \>1.9mmol/L in the first twelve hours of life
- \> 36 weeks gestational age
Exclusion
- Infants with symptomatic hypoglycemia (regardless of value
- Infants who meet criteria for intravenous dextrose according to the Canadian Pediatric Society (CPS) position statement
- Infants with contraindications for enteral feeds and/or medications
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00994149
Start Date
October 1 2009
End Date
October 1 2011
Last Update
October 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal University Hospital
Saskatoon, Saskatchewan, Canada, S7N 0W4